Pharmaceuticals — Editors

Journal Contact

Pharmaceuticals Editorial Office
MDPI AG, Postfach, CH-4005 Basel, Switzerland
E-Mail: pharmaceuticals@mdpi.com
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Editorial Office

Editor-in-Chief
Dr. Derek J. McPhee
Director of Chemistry, Amyris Biotechnologies, Inc., 5885 Hollis St, Suite 100, Emeryville, CA 94608, USA
Tel. +1 510 450 0761 xt 718; Fax: +1 510 225 2645
E-Mail: mcphee@mdpi.com
Interests: organic synthesis; medicinal chemistry; biotechnology

Managing Editor
Ms. Jely He
MDPI Beijing Office, Suite 2011, Ruidu International Center, No. 1 Cuijingbeili, Tongzhou District, Beijing, China
Tel. +86 10 81521170; Fax: +86 10 59011089
E-Mail: jely.he@mdpi.com

Publisher
Dr. Shu-Kun Lin
MDPI AG, Kandererstrasse 25, CH-4057 Basel, Switzerland
Tel. +41 79 322 33 79
Website: http://www.mdpi.org/lin/
E-Mail: lin@mdpi.com

Editorial Board

Prof. Dr. Peter J. Barnes
National Heart and Lung Institute, Imperial College, London, UK
Tel. +44 207 351 8174; Fax: +44 207 351 5675
Website: http://www1.imperial.ac.uk/medicine/people/p.j.barnes.html
E-Mail: p.j.barnes@imperial.ac.uk
Interests: molecular mechanisms and therapy of asthma and COPD
Contribution: Special Issue: Antiasthmatic Drugs

Prof. Dr. Fernanda Borges
BaseTEC and Department of Organic Chemistry, Faculty of Pharmacy, University of Porto, R. Aníbal Cunha, 164, 4050.047 Porto, Portugal
Tel. +351 222078900; Fax: +351 222003977
E-Mail: fborges@ff.up.pt
Interests: medicinal chemistry; Design and synthesis of new chemical entities (NCE) towards several targets mainly connected with cancer, Parkinson and Alzheimer and inflammatory diseases; lead discovery and optimisation; development of new antioxidants; synthesis and analysis of metabolites

Dr. Geoff Brown
Department of Chemistry, The University of Reading, Whiteknights, Reading, RG6 6AD, UK
Tel. +44 (0) 118 378 7418; Fax: +44 (0) 118 378 6331
Website: http://www.reading.ac.uk/chemistry/about/staff/g-d-brown.asp
E-Mail: g.d.brown@reading.ac.uk
Interests: *for Molecules specifically*: natural products; terpenes; biosynthesis; autoxidation chemistry; structure determination by NMR spectroscopy; prebiotic chemistry; *for Pharmaceuticals specifically*: natural products; antimalarial drugs; cannabinoids; NMR spectroscopy; metabonomics; oligosacharide structure determination
Contribution: In other journals:
Special Issue: Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary

Dr. Ian Churcher
Discovery Medicinal Chemistry, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, UK
Tel. +44 1438 762468; Fax: +44 1438 768232
E-Mail: ian.2.churcher@gsk.com
Interests: fragment-based drug design; structure-based design; kinases; pharmacokinetics; novel hit identification strategies; screening techniques and chemical diversity

Prof. Dr. Paul Cos
Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences Antwerp University, campus drie eiken, building S, office 7.26 Universiteitsplein 1, B-2610 Antwerp, Belgium
Website: http://www.ua.ac.be/paul.cos
E-Mail: paul.cos@ua.ac.be
Interests: anti-infective agents; biofilm; bacterial virulence; oxidative stress; antibacterial; antifungal; antiparasitic and antiviral
Contribution: Special Issue: Anti-Infective Agents
In other journals:
Special Issue: Anti-Infective Agents

Prof. Dr. Paul J. Dyson
Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland
Website: http://isic2.epfl.ch/page59045.html
E-Mail: paul.dyson@epfl.ch
Interests: metal drugs; platinum drugs; ruthenium drugs; organometallic drugs

Prof. Dr. Thomas Efferth
Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Staudinger Weg, 555128 Mainz, Germany
Tel. +49 6131 3925751; Fax: +49 6131 3923752
E-Mail: efferth@uni-mainz.de
Interests: cancer; pharmacogenomics; molecular docking and virtual drug screening; molecular pharmacology; natural products; phytotherapy
Contribution: Special Issue: Phytomedicine

Dr. David R. Gang
Departments of Plant Sciences and Biochemistry and Molecular Biophysics Member, BIO5 Institute, The University of Arizona Thomas W. Keating Bioresearch, Building 1657, E. Helen Street, Tucson, AZ 85721, USA
Tel. +1 520 621 7154; Fax: +1 520 626 4824
Website: http://ag.arizona.edu/research/ganglab/index.htm
E-Mail: gang@ag.arizona.edu
Interests: synthetic biology; metabolic engineering; biosynthesis; enzyme kinetics; structural biology; systems biology; metabolomics; mass spectrometry; proteomics; functional genomics; Alzheimers and inflammatory diseases; natural products; terpenoids; polyketides; alkaloids - especially Lycopodium alkaloids

Dr. Arthur Gomtsyan
Abbott Laboratories, 100 Abbott Park Road, Department R4PM, Bldg. AP10, Abbott Park, IL 60064, USA
Tel. +1 847 935 4214; Fax: +1 847 937 9195
E-Mail: arthur.r.gomtsyan@abbott.com
Interests: medicinal chemistry; synthetic organic chemistry; drug design in the area of pain research targeting ion channels and enzymes
Contribution: Special Issue: Advances in Drug Design

Dr. Gilles Gosselin
CNRS Research, Idenix Senior Scientist Fellow, Laboratoires IDENIX Sarl, Cap Gamma, 1682 Rue de la Valsière, B.P. 50001, 34189 Montpellier, Cedex 4, France
Tel. +33 (0)4 99 64 27 31; +33 (0)6 27 78 32 62 (mobile); Fax: +33 (0)4 67 63 73 26
Website: http://www.idenix.com/
E-Mail: gosselin.gilles@idenix.com
Interests: new nucleoside analogues as potential antiviral (AIDS, hepatitis) and antumor agents; nucleoside prodrugs; nucleotide prodrugs (pronucleotides)

Prof. Dr. Bernd Groner
Georg Speyer Haus, Institute for Biomedical Research, Paul Ehrlich Str. 42, D-60596 Frankfurt am Main, Germany
Tel. +49 69 63395180; Fax: +49 69 63395185
E-Mail: groner@em.uni-frankfurt.de
Interests: cytokine signal transduction; peptide inhibitors of oncoproteins; breast cancer research; experimental tumor therapy
Contribution: Special Issue: Peptide Drug Discovery and Development

Dr. Rick Gussio
National Cancer Institute, Division of Cancer Treament and Diagnosis, Developmental Therapeutics Program, Information Technology Branch, Target Structure-Based Drug Discovery Group, Frederick National Laboratory of Cancer Research, 8490 Progress Drive Riverside 5, Suite 400 Frederick, MD 21701, USA
Tel. +1 301 846 5791; Fax: +1 301 846 6106
E-Mail: gussior@mail.nih.gov
Interests: structural medicinal chemistry; structure-based design & discovery; molecular modeling, bioinformatics; chemoinformatics; applied statistics; QSAR; computational chemistry; pharmacognosy

Prof. Dr. Michael Gütschow
Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53115 Bonn, Germany
Tel. +49 228 732317
Website: http://www.pharma.uni-bonn.de/www/pharmchem1/gutschow-laboratory
E-Mail: guetschow@uni-bonn.de
Interests: synthetic organic chemistry; enzyme kinetics; mechanism-based enzyme inhibitors; inhibitors of proteases

Prof. Dr. Christian Hartinger
School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
E-Mail: c.hartinger@auckland.ac.nz
Interests: development of metal-based drugs; mode of action studies; interaction with biomolecules and bioanalytical chemistry with a focus on mass spectrometric techniques coupled to separation methods

Dr. Kenneth A. Jacobson
Laboratory of Bioorganic Chemistry and Molecular Recognition Section, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bldg. 8A, Rm. B1A-19, 8 Center Dr., MSC-0810 Bethesda, MD 20892-0810, USA
Tel. +1 301 496 9024; Fax: +1 301 496 9024
Website: http://www.researcherid.com/rid/A-1530-2009
E-Mail: kajacobs@helix.nih.gov
Interests: medicinal chemistry; G protein-coupled receptors; receptor pharmacology; cell signaling; molecular modeling; purinergic receptors; adenosine receptors; chemistry of nucleosides and nucleotides; radiochemistry; nanotechnology and nanoscience

Dr. Svend Borup Jensen
Nuklearmedicinsk Afdeling - Hobrovej 18-22, Postboks 365, 9100 Aalborg, Denmark
Tel. +45 9932 3140; Fax: +45 9932 3145
E-Mail: svbj@rn.dk
Interests: drug in-vitro degradation profiles; medicinal gum; analytical methods; medicinal chemistry; PET-radiochemistry
Contribution: Special Issue: Radiochemistry
In other journals:
Special Issue: Radiochemistry

Dr. Jos H.M. Lange
Principal Scientist Chemical Design & Synthesis Unit, Abbott Healthcare Products B.V., C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands
Tel. +31 0294 479731; Fax: +31 0294 477138
E-Mail: jos.lange@abbott.com
Interests: synthetic organic chemistry and microwave chemistry; CNS drug design; lead finding and lead optimization strategies; cannabinoids and cannabinoid receptor modulators; peptidomimetics

Dr. Bernard Le Foll
Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario M5S 2S1, Canada
Tel. +1 416.535.8501, ext. 4772
Website: http://www.pharmtox.utoronto.ca/faculty/directory/lefoll.htm
E-Mail: bernard_lefoll@camh.net
Interests: drug addiction; place conditioning; self-administration; preclinical models; dopamine; motivation; nicotine; ethanol; cannabinoid; randomized controlled trials; PET; pharmacogenetic

Prof. Dr. Philip S. Low
Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN 47906-2084, USA
Tel. +1 765 494 5273; Fax: +1 765 494 5272
Website: http://www.chem.purdue.edu/people/faculty/faculty.asp?itemID=44
E-Mail: plow@purdue.edu
Interests: targeted therapies for inflammatory and autoimmune diseases; targeted therapies for cancer; structure of the erythrocyte membrane; siRNA delivery; ligand-targeted imaging agents; nanomedicines; rapid detection and identification of pathogens

Prof. Dr. Giuseppe Mancia
Clinical Medicine Unit, University of Milano-Bicocca, San Gerardo Hospital, Via Pergolesi, 33, 20052 Monza (MI), Italy
Tel. +39 039 2333357; Fax: +39 039 322274
E-Mail: giuseppe.mancia@unimib.it
Interests: pathophysiology; clinical pharmacology and therapy of hypertension; congestive heart failure and other cardiovascular diseases
Contribution: Special Issue: Antihypertensive Drugs

Prof. Dr. Alberto M. Martelli
Dipartimento di Scienze Anatomiche Umane, Università di Bologna, Cell Signalling Laboratory, School of Pharmacy, via Irnerio 48, 40126 Bologna BO, Italy
Tel. +39 051 2091580; Fax: +39 051 2091695
E-Mail: alberto.martelli@unibo.it
Interests: targeted therapies for cancer; signal transduction pathways as innovative therapeutic targets; nuclear lipid-based signaling

Prof. Dr. Kevin H. Mayo
Department of Biochemistry, Molecular Biology & Biophysics, and the NCI-designated Comprehensive Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, USA
Tel. +1 612 625 9968
E-Mail: mayox001@umn.edu
Interests: protein and carbohydrate structure and function; NMR spectroscopy; structure-based drug design and discovery; angiogenesis; oncology; infectious disease

Prof. Dr. Paolo Montuschi
Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy
Tel. +39 06 30156092; Fax: +39 06 30156292
E-Mail: pmontuschi@rm.unicatt.it
Interests: asthma; chronic obstructive pulmonary disease (COPD); pharmacological therapy of asthma and COPD; allergy; non-invasive monitoring of lung inflammation; exhaled breath condensate; exhaled nitric oxide; electronic nose; metabolomics
Contribution: Special Issue: Antiasthmatic Drugs

Dr. Mark Murphy
Research Immunology, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH- 4123 Allschwil, Switzerland
Tel. +41 61 565 85 12
Website: http://www.actelion.com/
E-Mail: mark.murphy@actelion.com
Interests: immunology; targeted therapies for inflammatory and autoimmune diseases; signal transduction pathways as innovative therapeutic targets; stem cells; protein-protein interactions; targeted therapies for cancer; cytokines/chemokines
Contribution: Special Issue: Chemokines

Dr. Tam Nguyen
SAIC, National Cancer Institute-Frederick, P.O. Box B, FVC 310, Frederick MD, 21702, USA
Tel. +1 301 846 6035; Fax: +1 301 846 6106
E-Mail: nguyent@ncifcrf.gov
Interests: kinase inhibition; protein dynamics; chemoinformatics; structural chemistry; molecular modeling; NMR spectroscopy

Dr. Mark H. Norman
Therapeutic Discovery Amgen Inc., One Amgen Center Drive, MS: B29 29-M-B Thousand Oaks, CA 91320-1799, USA
Tel. +1 805 447 1552; Fax: +1 805 480 3015
E-Mail: markn@amgen.com
Interests: design and synthesis of new chemical entities (NCE) towards several targets mainly connected with cancer, pain and inflammation; lead discovery and optimization; medicinal chemistry

Dr. Emmanuel S. Onaivi
Department of Biology, William Paterson University, Wayne, NJ, 07470, USA
Tel. +1 973 720 3453
Website: http://euphrates.wpunj.edu/faculty/onaivie/
E-Mail: onaivie@wpunj.edu
Interests: cannabinoids; endocannabinoid system; cannabinoid genetics and epigenetics; drug addiction; medical marijuana and cannabinoid pharmacogenomics
Contribution: Special Issue: Medical Marijuana

Prof. Dr. Ricardo E. Pérez-Tomás
Department of Pathology and Experimental Therapy, Faculty of Medicine, University of Barcelona, Campus de Bellvitge., Lab.5101 C./ Feixa Llarga s/n E- 08907, Hospitalet de Llobregat, Barcelona, Spain
Tel. +34 93 4024288; Fax: +34 93 4024249
Website: http://www.ub.es/cellbiology/staff/ricardoperez.htm
E-Mail: rperez@ub.edu
Interests: new molecules for cancer chemotherapy; apoptosis; signal transduction for cancer chemotherapy

Prof. Dr. Yvonne Perrie
Aston Pharmacy School, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK
Tel. +44 1212 043991
Website: http://www1.aston.ac.uk/lhs/staff/az-index/perriey/
E-Mail: y.perrie@aston.ac.uk
Interests: liposomes; gene therapy; vaccines; colloidal systems; pharmaceutics; pharmaceutical education; drug delivery
Contribution: In other journals:
Special Issue: What's on Board in Pharmaceutics
Special Issue: Gene Therapy

Prof. Dr. Leonidas A. Phylactou
Head, Department of Molecular Genetics, Function & Therapy, The Cyprus Institute of Neurology & Genetics, PO Box 23462, 1683 Nicosia, Cyprus
Website: http://www.cing.ac.cy/mgft/
E-Mail: laphylac@cing.ac.cy
Interests: RNA biology; regulatory RNA molecules; muscle regeneration, identification of genetic defects in inherited diseases
Contribution: Special Issue: Gene Therapy

Prof. Dr. Thomas Rades
Reseach Chair in Pharmaceutical Design and Drug Delivery Faculty of Health and Medical Sciences, Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 København Ø, Denmark
E-Mail: thor@farma.ku.dk
Interests: formulation and drug delivery and physical characterization of drugs and dosage forms; colloidal delivery systems for bioactives; the solid state of drugs and dosage forms

Prof. Dr. Maurizio Recanatini
Department of Pharmaceutical Sciences, University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy
Tel. +39 051 20 99720; Fax: +39 051 20 99734
Website: http://www.unibo.it/
E-Mail: maurizio.recanatini@unibo.it
Interests: computational medicinal chemistry; structure-based ligand design & discovery; modeling of targets and ligand-target complexes of therapeutic interest (cancer, Alzheimer\'s disease, hERG-related drug toxicity); chemical biology
Contribution: Special Issue: Targeted Therapy

Dr. P. Hemachandra Reddy
Neurogenetics Laboratory, Neuroscience Division, Oregon National Primate Research Center, West Campus, Oregon Health and Science University, 505 N.W., 185th Avenue Beaverton, OR 97006, USA
Tel. +1 503 418 2625 (office); +1 503 418 2627 (lab); Fax: +1 503 418 2501
E-Mail: reddyh@ohsu.edu
Interests: aging; neurodegenerative diseases; gene expression analysis; transgenic mouse models; mitochondrial biology; mitochondrial function/dysfunction; mitochondrial therapeutics; mitochondrial dynamics
Contribution: Special Issue: Mitochondrial Drugs for Neurodegenerative Diseases
Special Issue: Genes, Mechanisms and Drugs for Asthma

Prof. Dr. Oliver Reiser
Institut für Organische Chemie, Universität Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany
Tel. +49 (0)941 943 4631(4630); Fax: +49 (0)941 943 4121
Website: http://www-oc.chemie.uni-regensburg.de/reiser/index.html
E-Mail: oliver.reiser@chemie.uni-regensburg.de
Interests: asymmetric catalysis; stereoselective synthesis; natural product; synthesis; unnatural amino acids; foldamers
Contribution: Special Issue: Asymmetric Synthesis and Medicinal Chemistry

Prof. Dr. Domenico Ribatti
Dipartimento di Scienze Mediche di Base,Sezione di Anatomia Umana e Istologia, Università degli Studi di Bari, Piazza G. Cesare 11, Policlinico, 70124 Bari, Italy
Tel. +39 080 5478240; Fax: +39 080 5478310
E-Mail: ribatti@anatomia.uniba.it
Contribution: Special Issue: Angiogenesis Inhibitors

Prof. Dr. Leandros A. Skaltsounis
Department of Pharmacognosy and Natural Products Chemistry, School of Pharmacy, University of Athens, Athens 15771, Greece
Tel. +302107274598; Fax: +302107274594
E-Mail: skaltsounis@pharm.uoa.gr
Interests: natural product chemistry; structure elucidation; medicinal chemistry; kinases inhibitors; functional food

Prof. Dr. Vladimir P. Torchilin
Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Mugar Building, Rm 312, 360 Huntington Avenue, Boston, MA 02129, USA
Tel. +617 373 3206; Fax: +617 373 7509
Website: http://www.northeastern.edu/bouve/directory/faculty.php?name=Vladimir%20P.%20Torchilin
E-Mail: v.torchilin@neu.edu
Interests: Drug carriers, Drug delivery sytems, Drug targeting, Liposomes, Micelles, Experimental cancer immunology, Imaging agents
Contribution: Special Issue: Cell-penetrating Peptides
In other journals:
Special Issue: Biodegradability of Materials
Special Issue: Micellar Drug Delivery

Dr. Sonia Tucci
School of Psychology, University of Liverpool, Eleanor Rathbone Building, Bedford Street South, Liverpool, L37 2LE, UK
Tel. +44 151 7941121; Fax: +44 151 794 2945
Website: http://www.liv.ac.uk/psychology-health-and-society/staff/sonia-tucci/
E-Mail: sonia.tucci@liv.ac.uk
Interests: behavioural neuroscience; psychopharmacology; neurochemical correlates of behaviour; mechanisms of appetite regulation; brain cannabinoid function in relation to appetite and body weight regulation
Contribution: Special Issue: Phytochemicals with actions on the Central Nervous System

Dr. Jean Jacques Vanden Eynde
Laboratory of Organic Chemistry (FS), University of Mons-UMONS, Place du parc, 20, B-7000 Mons, Belgium
Tel. +32 65 373337
Website: http://w3.umons.ac.be/~jjvde/lso.htm
E-Mail: jjvde@umons.ac.be
Interests: heterocycles; microwave-induced synthesis; solvent-free reactions; polymer (insoluble and soluble)-assisted syntheses; combinatorial chemistry; prodrugs
Contribution: Special Issue: Prodrugs
In other journals:
Special Issue: Prodrugs
Special Issue: Flow Chemistry

Dr. Howard A. Young
Principal Investigator & Deputy Lab Chief, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Bldg. 560/31-23, Chandler Street, Frederick, MD 21702-1201, USA
Tel. +1 301 846 5700; Fax: +1 301 846 1673
E-Mail: younghow@mail.nih.gov
Interests: interferon-gamma; post transcriptional regulation; NK cells; interleukins
Contribution: Special Issue: Interferons

Prof. Dr. Liangren Zhang
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
Tel. +86 10 82802567
E-Mail: liangren@bjmu.edu.cn
Interests: nucleosides and nucleotides; drug design and synthesis; molecular modeling

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert